Literature DB >> 8811009

A study of the cellular immune response to enteroviruses in humans: identification of cross-reactive T cell epitopes on the structural proteins of enteroviruses.

J Cello1, O Strannegård, B Svennerholm.   

Abstract

We have attempted to extend our understanding of the enteroviral cross-reactive T cell response in humans. Peripheral blood mononuclear cells (PBMC) from healthy donors were stimulated in vitro with six different serotypes of enterovirus and 15 synthetic peptides representing conserved regions in the four structural proteins of these viruses. Upon challenge with different antigens, PBMC from donors responded specifically with proliferation and production of interferon-gamma (IFN-gamma). In contrast, synthesis of interleukin-4 (IL-4) or IL-10 was not detected. A T cell response to each enterovirus serotype was recorded in all individuals even though not all individuals had serum neutralizing antibody against each virus. These data confirmed previous findings that human T cells recognize enteroviral cross-reactive epitopes. Analysis of the peptide-induced IFN-gamma production and proliferative response showed that the cross-reactive T cell epitopes are localized mainly in capsid protein VP2 and VP3 and to a lesser extent in VP1. Surprisingly, T cell epitopes were not identified in the most conserved structural protein of enterovirus, VP4. Immune responses were mediated by CD4+ T cells in association with MHC class II molecules. The sources of IFN-gamma in response to the most immunodominant cross-reactive T cell epitopes were CD4+, CD8+ and NK cells. The two latter subsets produced IFN-gamma provided CD4+ T cells were present. Since T helper 1 (Th1) cells can mediate an in vivo protective immune response against poliovirus infection in mice, our novel findings in humans merit further detailed characterization of T cells that recognize the enteroviral cross-reactive T cell epitopes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811009     DOI: 10.1099/0022-1317-77-9-2097

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio.

Authors:  Rahnuma Wahid; Martin J Cannon; Marie Chow
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Irregular poliovirus vaccination correlates to pulmonary edema of hand, foot, and mouth disease.

Authors:  Chaoyang Deng; Chunfu Yang; Junfeng Wan; Liye Zhu; Qibin Leng
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

3.  Antibody responses to antigenic sites 1 and 3 of serotype 3 poliovirus after vaccination with oral live attenuated or inactivated poliovirus vaccine and after natural exposure.

Authors:  T Herremans; J H Reimerink; T G Kimman; H G van Der Avoort; M P Koopmans
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

4.  Comparison of enterovirus-specific cellular immunity in two populations of young children vaccinated with inactivated or live poliovirus vaccines.

Authors:  S Juhela; H Hyöty; R Uibo; S H Meriste; O Uibo; M Lönnrot; M Halminen; O Simell; J Ilonen
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

5.  The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.

Authors:  Qunying Mao; Yiping Wang; Jie Shao; Zhifang Ying; Fan Gao; Xin Yao; Changgui Li; Qiang Ye; Miao Xu; Rongcheng Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015-02-25       Impact factor: 3.452

6.  Diagnostic potential of parechovirus capsid proteins.

Authors:  Annu Alho; Jane Marttila; Jorma Ilonen; Timo Hyypiä
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

7.  Viral interference induced by live attenuated virus vaccine (OPV) can prevent otitis media.

Authors:  Elina Seppälä; Hanna Viskari; Sanna Hoppu; Hanna Honkanen; Heini Huhtala; Olli Simell; Jorma Ilonen; Mikael Knip; Heikki Hyöty
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

8.  A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses.

Authors:  Ruicheng Wei; Chunfu Yang; Mei Zeng; Frances Terry; Kai Zhu; Chunhui Yang; Ralf Altmeyer; William Martin; Anne S De Groot; Qibin Leng
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

9.  Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice.

Authors:  Yue-Xiang Li; Hui Zhao; Rui-Yuan Cao; Yong-Qiang Deng; Jian-Feng Han; Shun-Ya Zhu; Jie Ma; Long Liu; E-De Qin; Cheng-Feng Qin
Journal:  Virol J       Date:  2014-05-06       Impact factor: 4.099

10.  Long-term immunogenicity studies of formalin-inactivated enterovirus 71 whole-virion vaccine in macaques.

Authors:  Chia-Chyi Liu; Chyi-Sing Hwang; Wun-Syue Yang; Dan-Chin Tsai; Sze-Hsien Wu; Ai-Hsiang Chou; Yen-Hung Chow; Suh-Chin Wu; Jen-Ren Wang; Jen-Ron Chiang; Chin-Cheng Huang; Chien-Hsiung Pan; Pele Chong
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.